Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1532 of 5804
-
Dutch study tracks COVID antivirals in High-Risk patients
Knowledge-focused CompletedNovel antiviral drugs can mark a turning point in the prevention and treatment of patients with Covid-19. Recently, several independent large phase-III RCTs have shown that the intravenous administration of one gift of neutralizing SARS-CoV-2 monoclonal antibodies can reduce the …
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
New program aims to stop post-surgery confusion in seniors
Prevention Recruiting nowCognitive complications, that is problems with thinking and memory, are incredibly common after surgery, occurring in 10-50% of all older surgical patients. These complications can take different forms, but one of the most common is postoperative delirium (POD), a short-term stat…
Phase: NA • Sponsor: Sunnybrook Health Sciences Centre • Aim: Prevention
Last updated Jun 26, 2026 15:51 UTC
-
Ear stimulation device could ease endometriosis pain
Symptom relief Recruiting now6-10% of women of childbearing age suffer from endometriosis, which is mainly manifested by dysmenorrhea, non-menstrual pelvic pain and dyspareunia. Several treatment strategies, including surgical ones, are proposed but they are sometimes insufficient because endometriosis-relat…
Phase: NA • Sponsor: Hopital Foch • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
Nasal spray could tame racing heart episodes at home
Symptom relief CompletedThis Open Label Extension study will enable eligible patients with Paroxysmal Supraventricular Tachycardia (PSVT) who have previously participated in a Milestone Pharmaceuticals clinical trial of etripamil NS for PSVT, to access continued treatment with etripamil NS, Patients who…
Phase: PHASE3 • Sponsor: Milestone Pharmaceuticals Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
New imaging showdown: can MBI replace MRI for High-Risk breast cancer detection?
Diagnosis Recruiting nowTo evaluate the diagnostic performance of Tc99m sestamibi (MBI) compared to breast MRI in women who are at high risk for developing breast cancer. To assess the relationship of tumor size, histologic subtype and location of lesion and how it affects lesion conspicuity and sensit…
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 12:07 UTC
-
New RNA vaccine takes on deadly brain cancers in kids and adults
Disease control Recruiting nowThe primary objective will be to demonstrate the manufacturing feasibility and safety, and to determine the maximum tolerated dose (MTD) of RNA-LP vaccines in (Stratum 1) adult patients with newly diagnosed GBM (MGMT low level or unmethylated in adults only) and (Stratum 2) in pe…
Phase: PHASE1 • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New eczema drug shows promise in long-term real-world study
Disease control OngoingAtopic dermatitis (AD) is a skin condition that may cause a rash and itching due to inflammation of the skin. Therapies spread over the skin may not be enough to control the AD in trial participants who require systemic anti-inflammatory treatment. This study will assess the real…
Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 08:15 UTC
-
Can a 16-Week family program stop diabetes in latino teens?
Prevention OngoingPurpose: This study will test the efficacy of a family-focused lifestyle intervention for reducing type 2 diabetes (T2D) risk factors and increasing Quality of Life (QoL) among high-risk Latino families.
Phase: NA • Sponsor: Arizona State University • Aim: Prevention
Last updated Jun 27, 2026 12:25 UTC
-
Daily custom radiation plans could cut breast cancer treatment delays
Disease control CompletedPostoperative radiotherapy is for the majority of breast cancer patients the standard of care. During postoperative radiotherapy, unexpected dosimetric deviations can occur due to breast contour changes resulting from resorption of postoperative breast or chest wall seroma/hemato…
Sponsor: Amsterdam UMC, location VUmc • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New drug cocktail targets Virus-Linked cancers in early trial
Disease control Recruiting nowBackground: Less toxic and more effective treatments are needed for cancers caused by viruses. These cancers include Hodgkin and non-Hodgkin lymphoma, hepatocellular carcinoma, head and neck cancer, nasopharyngeal carcinoma, gastric cancer, anal cancer, cervical cancer, vaginal …
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New hope for Crohn's: ustekinumab trial targets chinese patients
Disease control CompletedThe purpose of this study is to evaluate the clinical and endoscopic efficacy and safety of ustekinumab in Chinese participants with moderately to severely active Crohn's disease.
Phase: PHASE4 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 26, 2026 18:23 UTC
-
Sound waves vs. tumors: new ultrasound treatment tested for sarcoma
Disease control Recruiting nowAround 3,300 people are diagnosed with soft tissue sarcoma (STS) each year in the UK, and a significant proportion of STS diagnoses are in people aged under 30 years. STS can arise from various tissue types and is comprised of over 50 tumour types. Although STS is treated with a …
Phase: NA • Sponsor: Oxford University Hospitals NHS Trust • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Could one year of immunotherapy be enough for advanced melanoma?
Disease control OngoingThe OTIMAS study is a phase II trial designed to evaluate if the duration of one year of pembrolizumab immunotherapy for advanced metastatic melanoma has equivalent efficacy as the two-year duration of historical controls.
Phase: PHASE2 • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New heart implant could replace blood thinners for AFib patients
Disease control CompletedThe purpose of this study is to evaluate the safety and effectiveness of the Laminar Left Atrial Appendage Closure System to treat patients with non-valvular atrial fibrillation that cannot take, or a have a reason to seek an alternative to anticoagulant medications.
Phase: NA • Sponsor: Laminar, Inc. • Aim: Disease control
Last updated Jun 26, 2026 16:45 UTC
-
New combo tackles recurrent brain tumor: immunotherapy plus radiation before surgery
Disease control Recruiting nowThe purpose of this study is to assess the safety/tolerability/feasibility of pembrolizumab and radiation therapy before surgical resection in patients with recurrent glioblastoma as defined by treatment-related AEs and the number of patients who do not necessitate a delay in sur…
Phase: PHASE1, PHASE2 • Sponsor: Chirag G. Patil • Aim: Disease control
Last updated Jun 26, 2026 12:36 UTC
-
New study: could targeted radiation alone beat prostate cancer without hormone pills?
Disease control OngoingThe researchers are doing this study to find out if stereotactic body radiation therapy (SBRT) without androgen deprivation therapy (ADT) is an effective treatment approach for people with unfavorable intermediate-risk prostate. The researchers will see whether SBRT can prevent p…
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Experimental blood cancer drug trial halted early
Disease control TerminatedThis is an open-label, multicenter, Phase 1/Phase 2, dose escalation and dose expansion study to evaluate the safety, pharmacokinetics, pharmacodynamics and anti-leukemic activity of SAR443579 in various hematological malignancies.
Phase: PHASE1, PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New x-ray activated drug injection tested for Hard-to-Treat cancers
Disease control Recruiting nowIn this Phase I trial for subjects with advanced head \& neck cancer, breast cancer, soft tissue sarcoma or melanoma all subjects will receive open label X-PACT treatment as a intra-tumoral injection. The primary objective will be to establish the safety of X-PACT when dosed with…
Phase: PHASE1 • Sponsor: Immunolight, LLC • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Can a common antioxidant boost CAR T-Cell therapy for lymphoma?
Disease control OngoingThe purpose of this study is to test the safety of N-AC when given in combination with Yescarta to people with lymphoma. This study will test different doses of N-AC to find the highest dose that causes few or mild side effects in participants.
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New drug targets Hard-to-Treat cancers with PIK3CA mutation
Disease control Recruiting nowThis is an open-label, FIH study designed to evaluate the maximum tolerated dose, recommended Phase 2 dose, safety, tolerability, PK, pharmacodynamics, and preliminary antineoplastic activity of RLY-2608, in advanced solid tumor patients with a Phosphatidylinositol-4,5-bisphospha…
Phase: PHASE1 • Sponsor: Relay Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC